3 reports

  • Aqualis Completes Rights Offering Of Shares For US$9 Million
  • Aqualis Completes Private Placement Of Shares For US$4 Million

Its research and development activities focus on prescription drug products, OTC products and nutraceuticals.

  • Analgesic
  • Pain Relief
  • Pharmaceutical
  • Norway
  • Weifa

Partner ## Partner ## Deal status Deal category Deal sub-category Date of completion PARTNER ##: AVIPEP PTY., LTD.

  • Analgesic
  • Norway
  • Company
  • Corporate Finance
  • Algeta US, LLC

Parent company Company type Company information: Partners Partner ##: Ventana Medical Systems, Inc.

  • Analgesic
  • Salicylic Acid
  • Norway
  • M&A
  • Weifa